39 results
8-K
EX-99.1
ORIC
ORIC Pharmaceuticals Inc
11 Dec 23
Other Events
4:05pm
data demonstrated that ORIC-533 binds CD73 with high affinity and effectively blocks adenosine-driven immunosuppression in a high AMP environment
8-K
EX-99.2
bh923q4sti6
21 Dec 22
Other Events
5:25pm
8-K
EX-99.1
dql9iz6sm
8 Jul 21
ORIC Pharmaceuticals Announces FDA Clearance of IND Application for ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor
6:05am
8-K
EX-1.1
0898 n8uv5qr
6 May 21
Entry into a Material Definitive Agreement
5:10pm
DEF 14A
0vojnw
26 Apr 21
Definitive proxy
6:05am